Up next

Autoplay

Cancer Risk Great in Crohn's Disease Patients Treated with Combination Drug Therapy - IBD News

1 Views • 08/19/25
Share
Side Effects
Side Effects
Subscribers
0

John Kisiel, M.D., a gastroenterologist at Mayo Clinic, discusses a recently published article in Gastroenterology about the combination therapy of adalimumab and immunomodulators and the risk for nonmelanoma skin cancer and other cancers in patients with Crohn's disease.

Show more
0 Comments sort Sort By

Up next

Autoplay